Erika Lundgrin, MD
Specialty
Pediatric Endocrinology, Endocrinology
Accepting New Patients
Primary Location
UH Rainbow Babies and Children's Hospital
11100 Euclid Ave
Cleveland, OH 44106
Biography
- Assistant Professor, CWRU School of Medicine
Erika Lundgrin, MD, MS is an adult and pediatric endocrinologist who treats patients of all ages with endocrine problems, with a special interest in improving care for patients with diabetes.
Expertise
- Adrenal Disorders
- Diabetes
- Disorders of Growth
- Disorders of Puberty
- Endocrinology
- Pediatric Endocrinology and Metabolism
- Pituitary Disorders
- Thyroid Disorders
Videos
Watch to find out more about this University Hospitals provider.
Languages Spoken
English
Office Locations
UH Rainbow Babies and Children's Hospital
11100 Euclid Ave
Cleveland, OH 44106
216-844-7700
UH Minoff Health Center at Chagrin Highlands
3909 Orange Pl
Suite: 3100
Beachwood, OH 44122
216-896-1774
Landerbrook II HC Ste 100 Monarch
5885 Landerbrook Dr
Suite: 100 Monarch
Mayfield Heights, OH 44124
216-844-8500
UH Landerbrook Health Center
5850 Landerbrook Dr
Suite: 220
Mayfield Heights, OH 44124
440-646-8055
DO 5885 Landerbrook
5885 Landerbrook Dr
Suite: 100
Mayfield Heights, OH 44124
216-844-8500
Certifications & Memberships
- Pediatric Endocrinology - American Board of Pediatrics
- Endocrinology, Diabetes and Metabolism - American Board of Internal Medicine
- Pediatrics - American Board of Pediatrics
- Internal Medicine - American Board of Internal Medicine
Education
Fellowship | Adult and Pediatric Endocrinology
Adult and Pediatric Endocrinology - UH Cleveland Medical Center (2017 - 2021)
Residency | Internal Medicine/Pediatrics
Internal Medicine/Pediatrics - UH Cleveland Medical Center (2013 - 2017)
Medical Education
Case Western Reserve University School Of Medicine (2013)
Other Education
Case Western Reserve University (2013)
Undergraduate
University Of California Berkeley (2006)
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Erika Lundgrin did not disclose any Outside Relationships with Industry.